ATE217004T1 - Synthese von conduritolepoxiden und aziridinen und verfahren zur synthese höherer disaccharide und deren verwendung - Google Patents

Synthese von conduritolepoxiden und aziridinen und verfahren zur synthese höherer disaccharide und deren verwendung

Info

Publication number
ATE217004T1
ATE217004T1 AT95923887T AT95923887T ATE217004T1 AT E217004 T1 ATE217004 T1 AT E217004T1 AT 95923887 T AT95923887 T AT 95923887T AT 95923887 T AT95923887 T AT 95923887T AT E217004 T1 ATE217004 T1 AT E217004T1
Authority
AT
Austria
Prior art keywords
aziridines
conduritolepoxides
disaccharides
synthesis
synthesizing higher
Prior art date
Application number
AT95923887T
Other languages
English (en)
Inventor
Tomas Hudlicky
Original Assignee
Virginia Tech Intell Prop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intell Prop filed Critical Virginia Tech Intell Prop
Application granted granted Critical
Publication of ATE217004T1 publication Critical patent/ATE217004T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/26—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95923887T 1994-06-17 1995-06-14 Synthese von conduritolepoxiden und aziridinen und verfahren zur synthese höherer disaccharide und deren verwendung ATE217004T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26158694A 1994-06-17 1994-06-17
PCT/US1995/007601 WO1995035303A1 (en) 1994-06-17 1995-06-14 Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides

Publications (1)

Publication Number Publication Date
ATE217004T1 true ATE217004T1 (de) 2002-05-15

Family

ID=22993964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95923887T ATE217004T1 (de) 1994-06-17 1995-06-14 Synthese von conduritolepoxiden und aziridinen und verfahren zur synthese höherer disaccharide und deren verwendung

Country Status (6)

Country Link
EP (1) EP0765336B1 (de)
JP (1) JP4064451B2 (de)
AT (1) ATE217004T1 (de)
CA (1) CA2193097C (de)
DE (1) DE69526581T2 (de)
WO (1) WO1995035303A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627280A (en) * 1995-02-16 1997-05-06 Virginia Tech Intellectual Properties, Inc. Synthesis of (+)-pancratistatin
US5777137A (en) * 1995-11-01 1998-07-07 University Of Florida Pancratistatins and processes for their production

Also Published As

Publication number Publication date
DE69526581T2 (de) 2002-12-19
CA2193097A1 (en) 1995-12-28
JPH10502059A (ja) 1998-02-24
CA2193097C (en) 2007-12-04
WO1995035303A1 (en) 1995-12-28
EP0765336A1 (de) 1997-04-02
JP4064451B2 (ja) 2008-03-19
DE69526581D1 (de) 2002-06-06
EP0765336B1 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
BR9709350A (pt) Membro de ligação especìfico, comp[osição farmacêutica, ácido nuclieco, célula hospedeira, uso de um membro de ligação especìfico e processo para sua produção
DE69611442D1 (de) Enzymatische synthese von glykosidischen verbindungen
BR9712285A (pt) Tetrafosfonato bicìclico de trianidridas
CA2174033A1 (fr) Nouveaux composes pyridiniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
ATE245646T1 (de) Therapeutische nukleoside
ATE229078T1 (de) Methode zur synthese von amino-deoxy- disacchariden und amino-deoxy-oligosacchariden
BR9304678A (pt) Glicidiléteres contendo grupos ciclohexila, processo para sua preparação, aplicação desses glicidiéteres e compostos
GR3023040T3 (en) Substituted indoles as anti-aids pharmaceuticals
DE69509161D1 (de) Hydroxylgruppen enthaltende Triaminkatalysatorzusammensetzungen zur Polyurethanherstellung
WO1997014712A3 (de) Sulfamat-derivate von 1,3,5(10)-estratrien-derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATE355295T1 (de) Synthese von oligosacchariden, reagenzien und verfahren
GR71207B (de)
AU7242687A (en) Nucleic acid and methods for the synthesis of novel DAF compositions
BR9407257A (pt) Composto do tipo bis-naftalimida composição farmacêutica processo para tratamento de um tumor em mamifero uso do composto do tipo bis-naftalimida e processo para a preparação compostos do tipo bis-naftalimida
FI950817A7 (fi) Uudet bentsodioksaaniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
ATE217004T1 (de) Synthese von conduritolepoxiden und aziridinen und verfahren zur synthese höherer disaccharide und deren verwendung
ES2148658T3 (es) Sistema espesante para mezclas de materiales de construccion.
MX168839B (es) Procedimiento para la obtencion de olefinas terciarias mediante descomposicion de eteres alquil-ter alquilicos
DE69010956D1 (de) Verfahren zur Synthese von Acylaminogruppen enthaltenden Siliziumverbindungen.
ATE103945T1 (de) Kalthaertende reaktionsharzmischung und deren verwendung.
ATE247955T1 (de) Selenophen-antitumormittel
IT1190116B (it) Processo per la sintesi di mono o di idrossifluoroalcani
PT91873A (pt) Processo para a preparacao de composicoes farmaceuticas contendo acidos oxapenem-3-carboxilicos estaveis uteis como inibidores de beta-lactamase
ES538230A0 (es) Procedimiento para la preparacion de nuevos derivados de n-(metoxifenacil)-amina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties